However, it has been suggested that malignant disease might be associated with a low selenium status as a consequence of modified metabolism in cancer cells due to tumor-associated inflammation and reduced selenoprotein biosynthesis in the liver or due to predisposition [25, 26]. This evidence concerns the gene SELENOS and neoplasm.